Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs
Human neural cell models derived from induced pluripotent stem cells (iPSCs) have been widely accepted to model various neurodegenerative diseases such as Alzheimer’s disease (AD) in vitro. Although the most common sources of iPSCs are fibroblasts and peripheral blood mononuclear cells, the collecti...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Aging Brain |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589958923000385 |
| _version_ | 1827596325857787904 |
|---|---|
| author | Sopak Supakul Yuki Hatakeyama Nicolas Leventoux Maika Itsuno Naoko Numata Hayato Hiramine Satoru Morimoto Atsushi Iwata Sumihiro Maeda Hideyuki Okano |
| author_facet | Sopak Supakul Yuki Hatakeyama Nicolas Leventoux Maika Itsuno Naoko Numata Hayato Hiramine Satoru Morimoto Atsushi Iwata Sumihiro Maeda Hideyuki Okano |
| author_sort | Sopak Supakul |
| collection | DOAJ |
| description | Human neural cell models derived from induced pluripotent stem cells (iPSCs) have been widely accepted to model various neurodegenerative diseases such as Alzheimer’s disease (AD) in vitro. Although the most common sources of iPSCs are fibroblasts and peripheral blood mononuclear cells, the collection of these cells is invasive. To reduce the donor’s burden, we propose the use of urine-derived cells (UDCs), which can be obtained non-invasively from a urine sample. However, the collection of UDCs from elderly donors suffering from age-related diseases such as AD has not been reported, and it is unknown whether these UDCs from the donor aged over 80 years old can be converted into iPSCs and differentiated into neural cells. In this study, we reported a case of using the UDCs from the urine sample of an 89-year-old AD patient, and the UDCs were successfully reprogrammed into iPSCs and differentiated into neural cells in four different ways: (i) the dual SMAD inhibition with small-molecules via the neural progenitor precursor stage, (ii) the rapid induction method using transient expression of Ngn2 and microRNAs without going through the neural progenitor stage, (iii) the cortical brain organoids for 3D culture, and (iv) the human astrocytes. The accumulation of phosphorylated Tau proteins, which is a pathological hallmark of AD, was examined in the neuronal models generated from the UDCs of the aged donor. The application of this cell source will broaden the target population for disease modeling using iPS technology. |
| first_indexed | 2024-03-09T03:08:59Z |
| format | Article |
| id | doaj.art-5cff9b1ff6d34f399063dad06d1650ce |
| institution | Directory Open Access Journal |
| issn | 2589-9589 |
| language | English |
| last_indexed | 2024-03-09T03:08:59Z |
| publishDate | 2023-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Aging Brain |
| spelling | doaj.art-5cff9b1ff6d34f399063dad06d1650ce2023-12-04T05:23:57ZengElsevierAging Brain2589-95892023-01-014100101Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCsSopak Supakul0Yuki Hatakeyama1Nicolas Leventoux2Maika Itsuno3Naoko Numata4Hayato Hiramine5Satoru Morimoto6Atsushi Iwata7Sumihiro Maeda8Hideyuki Okano9Department of Physiology, Keio University School of Medicine, 160-8582 Tokyo, JapanDepartment of Physiology, Keio University School of Medicine, 160-8582 Tokyo, JapanDepartment of Physiology, Keio University School of Medicine, 160-8582 Tokyo, JapanDepartment of Physiology, Keio University School of Medicine, 160-8582 Tokyo, JapanDepartment of Physiology, Keio University School of Medicine, 160-8582 Tokyo, JapanJSR-Keio University Medical and Chemical Innovation Center (JKiC), JSR Corporation, 160-8582 Tokyo, JapanDepartment of Physiology, Keio University School of Medicine, 160-8582 Tokyo, Japan; Department of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 173-0015 Tokyo, JapanDepartment of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 173-0015 Tokyo, JapanDepartment of Physiology, Keio University School of Medicine, 160-8582 Tokyo, Japan; Corresponding authors.Department of Physiology, Keio University School of Medicine, 160-8582 Tokyo, Japan; Corresponding authors.Human neural cell models derived from induced pluripotent stem cells (iPSCs) have been widely accepted to model various neurodegenerative diseases such as Alzheimer’s disease (AD) in vitro. Although the most common sources of iPSCs are fibroblasts and peripheral blood mononuclear cells, the collection of these cells is invasive. To reduce the donor’s burden, we propose the use of urine-derived cells (UDCs), which can be obtained non-invasively from a urine sample. However, the collection of UDCs from elderly donors suffering from age-related diseases such as AD has not been reported, and it is unknown whether these UDCs from the donor aged over 80 years old can be converted into iPSCs and differentiated into neural cells. In this study, we reported a case of using the UDCs from the urine sample of an 89-year-old AD patient, and the UDCs were successfully reprogrammed into iPSCs and differentiated into neural cells in four different ways: (i) the dual SMAD inhibition with small-molecules via the neural progenitor precursor stage, (ii) the rapid induction method using transient expression of Ngn2 and microRNAs without going through the neural progenitor stage, (iii) the cortical brain organoids for 3D culture, and (iv) the human astrocytes. The accumulation of phosphorylated Tau proteins, which is a pathological hallmark of AD, was examined in the neuronal models generated from the UDCs of the aged donor. The application of this cell source will broaden the target population for disease modeling using iPS technology.http://www.sciencedirect.com/science/article/pii/S2589958923000385UrineInduced pluripotent stem cell (iPSC)Disease modelingNeuronsCortical brain organoidsAstrocytes |
| spellingShingle | Sopak Supakul Yuki Hatakeyama Nicolas Leventoux Maika Itsuno Naoko Numata Hayato Hiramine Satoru Morimoto Atsushi Iwata Sumihiro Maeda Hideyuki Okano Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs Aging Brain Urine Induced pluripotent stem cell (iPSC) Disease modeling Neurons Cortical brain organoids Astrocytes |
| title | Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs |
| title_full | Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs |
| title_fullStr | Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs |
| title_full_unstemmed | Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs |
| title_short | Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs |
| title_sort | urine derived cells from the aged donor for the 2d 3d modeling of neural cells via ipscs |
| topic | Urine Induced pluripotent stem cell (iPSC) Disease modeling Neurons Cortical brain organoids Astrocytes |
| url | http://www.sciencedirect.com/science/article/pii/S2589958923000385 |
| work_keys_str_mv | AT sopaksupakul urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT yukihatakeyama urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT nicolasleventoux urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT maikaitsuno urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT naokonumata urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT hayatohiramine urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT satorumorimoto urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT atsushiiwata urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT sumihiromaeda urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs AT hideyukiokano urinederivedcellsfromtheageddonorforthe2d3dmodelingofneuralcellsviaipscs |